drdo

DCGI approves anti-COVID drug developed by DRDO for emergency use

An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO),

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
error: Content is protected !!